Bharat Biotech is advancing vaccines to fight drug resistance, focusing on preventing hospital infections and reducing antibiotic use as antimicrobial resistance grows into a major global health threat.
Zydus Lifesciences has partnered with Lupin to roll out its weight loss injection in India, expanding access to semaglutide in India for diabetes and obesity treatment as demand rises across the country.
Alkem Laboratories’ Baddi manufacturing facility in India receives Germany GMP certificate, validating compliance with international quality standards and boosting its global pharmaceutical presence.
Mankind Pharma is preparing to enter India’s fast-growing semaglutide market as the patent expiry opens doors for local drugmakers. The company plans an early launch to capture demand for diabetes and weight-loss treatments.
The Centre proposes reforms to simplify drug testing for plasma-derived medicines, eliminating redundant virus tests while ensuring high safety standards for patients.
FDA expands approval of GSK’s Arexvy RSV vaccine to high-risk adults aged 18–49, widening protection against severe respiratory infections and supporting broader adult immunization strategies.
Abbott introduces XIENCE Skypoint in India, an advanced stent for treating complex heart blockages. It offers greater flexibility, precision, and improved treatment options for patients.
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has urged Indian pharmaceutical exporters to diversify shipping routes and explore alternative logistics options as tensions in the Gulf region threaten key global trade corrid...
Neuland Laboratories is expanding into commercial peptide manufacturing with a new facility at its Bonthapally campus near Hyderabad. The first module, expected by summer 2026, already has USD 30 million in customer commitments.
CDMOs are stepping up investments and expanding facilities as global pharma turns to them for complex drug development. Advanced therapies and biologics are driving this surge.